Ultralife (NASDAQ:ULBI) Posts Earnings Results, Misses Estimates By $0.09 EPS

Ultralife (NASDAQ:ULBI) announced its quarterly earnings results on Thursday. The technology company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.09), FiscalAI reports. Ultralife had a negative net margin of 3.50% and a positive return on equity of 2.75%. The firm had revenue of $48.27 million during the quarter, compared to analyst estimates of $56.00 million.

Ultralife Stock Up 0.1%

Ultralife stock traded up $0.01 during midday trading on Thursday, reaching $15.63. The stock had a trading volume of 242,421 shares, compared to its average volume of 65,842. The firm’s fifty day simple moving average is $7.24 and its 200-day simple moving average is $6.60. Ultralife has a 1-year low of $4.90 and a 1-year high of $15.69. The stock has a market capitalization of $260.40 million, a P/E ratio of -39.08 and a beta of 0.63. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.30 and a current ratio of 2.87.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Ultralife in a report on Wednesday, September 9th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation is a New York-based manufacturer of power and communications products serving government, defense, aerospace, industrial, medical and other specialized markets. The company develops and produces batteries, battery packs, chargers and related power-management products designed for portable and mission-critical equipment.

Ultralife’s product portfolio includes lithium primary and rechargeable batteries, custom battery assemblies, military battery systems, charging equipment and accessories.